Editorial: Real-Life Data Confirm Efficacy of Elbasvir/Grazoprevir in HCV Patients With Severe Kidney Disease
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14792
Full Text
Open PDFAbstract
Available in full text
Date
June 25, 2018
Authors
Publisher
Wiley